A multifunctional air filter combining metal-organic frameworks (MOFs) with commercial MERV-13 filters to capture volatile organic compounds (VOCs) and inactivate airborne pathogens in a single device. Prototype data shows comparable particle filtration, 61.5% toluene removal, and strong antimicrobial activity against bacteria and viruses.
Indoor and workplace air quality is a growing concern as facilities seek protection against both chemical vapors and biological contaminants. This solution integrates metal-organic frameworks (MOFs), highly porous crystalline materials built from organic linkers and metal ions, onto standard commercial air filters to deliver dual-function air cleaning. The technology targets simultaneous removal of volatile organic compounds (VOCs) and airborne pathogens such as bacteria and viruses, addressing a gap left by conventional filters that address only particulates.
The approach leverages two biosafe MOF platforms: a zirconium-based MOF coated with a positively charged antimicrobial polymer for face-mask applications, and a titanium-based MOF applied to commercial MERV-13 filters for HVAC and building ventilation use. The result is a drop-in filter upgrade that adds VOC adsorption and antimicrobial function without sacrificing baseline particle filtration performance.
Key features:
How it works: The MOF's intrinsic porosity captures VOC molecules through adsorption, while the surface-engineered antimicrobial coating inactivates pathogens on contact as air passes through the filter.
The technology is at an advanced prototype stage (TRL 5–6). A titanium-based MOF-coated MERV-13 filter has been validated against ISO particle filtration standards and tested for VOC adsorption and antimicrobial performance. A separate electrospun nanofibrous MOF prototype has demonstrated N95-level filtration and greater than 95% antibacterial efficiency in laboratory testing.
Next-stage validation planned (1–2 years):
The research team is actively seeking partnership support for expanded biological validation and is open to co-development arrangements to advance the filter toward commercial readiness.
Virginia Commonwealth University is a comprehensive public research university and academic health center in Richmond, combining broad disciplinary breadth with a downtown, two‑campus footprint and top‑tier (R1) research activity. Integration with VCU Health enables large‑scale clinical research and translation, while shared core research facilities support collaborative, industry‑oriented R&D. Its urban location places faculty and students adjacent to the VA Bio+Tech Park and within a growing Mid‑Atlantic innovation corridor, and an optional engineering co‑op program creates a reliable talent pipeline for partners. Research is backed by competitive federal funding, including NIH and NSF. VCU TechTransfer and Ventures manages IP, licensing and startup formation.